The Association between Antiphospholipid and Coagulation in Pregnant Women with Blood Clotting
Medical Journal of Babylon, ISSN: 2312-6760, Vol: 21, Issue: Suppl 2, Page: S272-S275
2024
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Mentions1
- News Mentions1
- News1
Most Recent News
Research from University of Tikrit Has Provided New Data on Health and Medicine (The Association between Antiphospholipid and Coagulation in Pregnant Women with Blood Clotting)
2024 DEC 05 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Daily -- Data detailed on agriculture have been presented. According
Article Description
Background: Antiphospholipid syndrome is a systemic hematological autoimmune disease characterized by a hypercoagulable state, which is associated with vascular thrombosis and/or obstetric morbidity characterized by miscarriage, fetal death, and/or premature birth. Objective: This research study aimed to estimate anticardiolipin [ACL; immunoglobulin (Ig)G and IgM] and lupus anticoagulant (LA) in pregnant women who have blood clots or who have previously miscarried and fetal intrauterine mortality. Materials and Methods: This study included 90 women, 60 of whom were pregnant women who had blood clots or had previously miscarried, as well as 30 nonpregnant women as a control group, aged from 20 to 41 years, from October 2022 to April 2023. The patients were referred to the Department of Gynecology and Obstetrics at a Teaching Hospital, Salahuddin. LA, ACL IgM, and ACL IgG were detected in serum by the enzyme-linked immunosorbent assay. Results: This study found that pregnant women have higher ACL IgM and IgG levels than nonpregnant women. The mean concentration (mean ±standard error) for ACL IgM was 23.43 ± 1.4, whereas ACL IgG was 33.11 ± 1.28, which is in contrast with the control group of ACL IgM (2.99 ± 0.22) and ACL IgG (3.51 ± 0.29). The differences were statistically significant (P = 0.0001). A significant increase in LA in pregnant women was 37.77 ± 1.14, whereas the control group had a lower mean amount of LA was 334.42 ± 1.05. Statistically significant differences were observed (P ≤ 0.05). Conclusion: Elevated levels of ACL and LA are the main cause of spontaneous recurrent abortions in women.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know